A Randomized Trial for the Assessment of Immunogenicity and Safety of Four Different Dosing Regimens of BioThrax(Rm) for Post-Exposure Prophylaxis for Anthrax in Adults
Phase of Trial: Phase IV
Latest Information Update: 16 Sep 2014
At a glance
- Drugs Anthrax vaccine (Primary)
- Indications Anthrax
- Focus Pharmacodynamics
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Apr 2013 Planned End Date changed from 1 Feb 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 14 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.